Actively Recruiting
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
Led by University of California, Los Angeles · Updated on 2026-04-15
167
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
V
VA Office of Research and Development
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot pre-post trial will address a gap in knowledge related to addressing modifiable risk factors for cardiometabolic disease through treating residual insomnia, sleep difficulties that remain after successful treatment of another condition, in the context of PTSD in understudied older adults. This study provides a non-medication treatment for PTSD called Cognitive Processing Therapy (CPT) followed by a non-medication sleep education and treatment program (Cognitive Behavioral Therapy for Insomnia, CBT-I) for sleep problems that remain after completing PTSD treatment in older adults with PTSD. The aims of this project are to evaluate 1) the added benefits of treating residual insomnia on sleep and PTSD symptoms; 2) the added benefits of treating residual insomnia following CPT on cardiometabolic risk biomarkers and quality of life; and 3) the durability of the sleep, PTSD, cardiometabolic and quality of life benefits of treating residual insomnia following CPT at 6-month follow-up in older adults with PTSD.
CONDITIONS
Official Title
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Community-dwelling Veterans aged 50 years and older
- Received care from a Veterans Health Administration (VHA) facility in the prior year
- Diagnosis of PTSD
- Diagnosis of insomnia disorder
- Lives within a 50-mile radius of the research offices at the VA Sepulveda Ambulatory Care Center
You will not qualify if you...
- Active substance use or in recovery with less than 90 days of sobriety
- Too ill to engage in the study procedures (e.g., unable to attend the in-person meetings)
- Unable to self-consent to participate
- Unstable housing (as this will impact the research team's ability to retrieve costly and difficult to replace monitoring equipment)
- Severe cardiovascular or respiratory disease (e.g., ventilatory failure, CHF)
- Unstable medical or psychiatric disorders (which are a contraindication for behavioral treatment of insomnia)
- Comorbid sleep disorders (i.e., central sleep apnea syndrome, diagnosed narcolepsy or circadian rhythm sleep-wake phase disorders) based on medical record review and baseline assessment data, or untreated, severe sleep disordered breathing (SDB) as assessed via WatchPAT or previous clinical evaluation (apnea-hypopnea index [AHI] 64 30; or AHI 64 15 plus Epworth Sleepiness Scale [ESS] score 64 10) that better explain sleep difficulties
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VA Greater Los Angeles Healthcare System
North Hills, California, United States, 91343
Actively Recruiting
Research Team
M
Monica Kelly, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here